共 50 条
DIABETIC NEPHROPATHY IN 2014 Improved cardiorenal prognosis in diabetic nephropathy
被引:10
|作者:
Parving, Hans-Henrik
[1
]
Rossing, Peter
[2
]
机构:
[1] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark
[2] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
关键词:
BARDOXOLONE METHYL;
TYPE-2;
ALBUMINURIA;
MORTALITY;
D O I:
10.1038/nrneph.2014.238
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
In 2014, key studies in the field of diabetic nephropathy highlighted the importance of albuminuria as a predictor of cardiovascular risk and showed that the incidence of renal and cardiovascular complications is decreasing. Promising efficacy data were obtained with atrasentan, whereas a trial of bardoxolone methyl led to safety concerns.
引用
收藏
页码:68 / 69
页数:2
相关论文